Abbott Laboratories
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $12.63B | $47.66B | $7.62B |
| FY2025 | $9.90B | $52.13B | $8.52B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $12.63B | $47.66B | $7.62B |
| FY2025 | $9.90B | $52.13B | $8.52B |